Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aryl Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112047925B details a copper-catalyzed oxidative amination route for N-(aryl/heteroaryl) alkyl-diamides, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN114213272B details a novel copper-catalyzed carbonylation method for arylethynyl formamides, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111690947A details a green electrochemical method for trifluoromethylated aryl amides, offering metal-free synthesis and high yields for reliable pharmaceutical intermediate supply chains.
Novel Pd-catalyzed carbonylation method using benzyl formate. High purity aryl acetamides for pharma. Cost-effective and scalable process.
Discover a novel Pd-catalyzed method for aryl acetamide synthesis using benzyl formate. This patent offers safer, oxidant-free routes for high-purity pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method using benzyl formate. High yields, broad substrate scope, no external oxidant required for tertiary amines.
Patent CN111690947B reveals a metal-free electrochemical synthesis for trifluoromethylated arylamides, offering significant cost reduction in API manufacturing and greener processing.
Novel Pd-catalyzed carbonylation using benzyl formate for high-purity aryl acetamides. Reduces oxidant use and simplifies supply chains for pharma intermediates.
Patent CN112047879B details a novel copper-catalyzed method for selective halogenation, offering cost-effective and scalable solutions for API intermediate manufacturing.
Patent CN111978194B reveals a novel Pd-catalyzed route for aryl acetamides using benzyl formate. Offers safer, scalable manufacturing for pharmaceutical intermediates.
Patent CN112125843B reveals a green Oxone-mediated route for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN107628964B reveals mild carbonylation for N-aryl benzamides. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN108610304B details a novel Pd-catalyzed C-H activation route for diaryl sultams, offering superior atom economy and simplified supply chains for pharmaceutical intermediates.
Novel patent CN111978194A details a safe carbonylation method using benzyl formate. Offers cost-effective routes for high-purity pharmaceutical intermediates with simplified supply chains.
Novel Pd-catalyzed carbonylation method using benzyl formate. High yield, broad substrate scope, cost-effective for pharma intermediates.
Patent CN107628964B enables mild carbonylation. Reduces cost and improves supply chain for pharma intermediates. High purity and scalable production.
Patent CN112125843B details a green, metal-free synthesis of 3-hydroxymethyl-4-phenyl-3,4-dihydroquinolinones using Oxone. Discover cost-effective manufacturing strategies for high-purity pharmaceutical intermediates.
Patent CN112125843B reveals a metal-free Oxone-mediated route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Novel Pd-catalyzed carbonylation method using benzyl formate. High yields, mild conditions, scalable process for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method using benzyl formate. High yield, broad scope, cost-effective for pharma intermediates.